COMPANY

CellFE

Location: Hayward, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1.05M (SBIR Phase II 1R44CA310250-01, new, notice Sep 17, 2026). NIH RePORTER 1R44CA310250-01 (Sep 17, 2026)
Evidence (1 event)
- Sep 17, 2026 · NIH RePORTER 1R44CA310250-01
  Organization: CELLFE INC.; City/State: ATLANTA, GA; Project number: 1R44CA310250-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 1052108; Administering IC: National Cancer Institute; Project title: High throughput, high efficiency, rapid mechanical transfection for CAR T-cell therapeutics; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Sep 17, 2026 Grant Government grant — SBIR: $1.05M (annual award, as published), announced Sep 17, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Aug 20, 2025 Grant Government grant — SBIR: $314,000 (annual award, as published), announced Aug 20, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗
May 13, 2025 Partnership Partnership / licensing announced May 13, 2025. Source: company's own press page. source ↗

Last 2 years.

May 13, 2025 Partnership / licensing announced May 13, 2025. Source: company's own press page. source ↗
Sep 17, 2026 Government grant — SBIR: $1.05M (annual award, as published), announced Sep 17, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Aug 20, 2025 Government grant — SBIR: $314,000 (annual award, as published), announced Aug 20, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗